Skip to content
What is alpha-gal syndrome?
Another tick-driven disease has found its way into existence: alpha-gal syndrome, which is thought to begin with the bite of a Lone Star tick […]
What is alpha-gal syndrome? Read More »
Health
NIH Innovation Zone: Quivive Pharma’s solution for opioid use disorder and treatment
As part of our coverage of the National Institute of Health’s (NIH) Innovation Zone at the 2023 Biotechnology Innovation Organization (BIO) International Convention, Bio.News
NIH Innovation Zone: Quivive Pharma’s solution for opioid use disorder and treatment Read More »
House introduces bills to strengthen Vaccine Injury Compensation Program (VICP)
On August 4, U.S. lawmakers introduced two new bills in an effort to further strengthen the Vaccine Injury Compensation Program (VICP) and help the
House introduces bills to strengthen Vaccine Injury Compensation Program (VICP) Read More »
Without clinical trial diversity, we’re ‘losing a lot of opportunity’
In 2022, Congress enacted the Food and Drug Omnibus Reform Act, also known as FDORA, which requires drug sponsors to submit diversity action plans
Without clinical trial diversity, we’re ‘losing a lot of opportunity’ Read More »
How amputees give voice to AMR
Photo: BIO’s Emily Wheeler (second from left) with Jean Mwale, Amputee Coalition regional ambassador and sepsis survivor (right), at the Amputee Coalition 2023 National
How amputees give voice to AMR Read More »
Science and compassion merge to help women handle post-partum depression
The U.S. Food and Drug Administration (FDA) on August 4 approved the first oral medication, Zurzuvae (zuranolone), for the treatment of post-partum depression (PPD).
Science and compassion merge to help women handle post-partum depression Read More »
FDA approves new solution for quickly reversing impact of blood thinners
If you take a “blood thinning” medication like Warfarin and then require an urgent procedure or emergency surgery, what can doctors do to protect
FDA approves new solution for quickly reversing impact of blood thinners Read More »
CDC recommends routine use of RSV monoclonal antibody for infants
The Centers for Disease Control and Prevention (CDC) added a recently approved monoclonal antibody (mAb) for respiratory syncytial virus (RSV) prevention to the list
CDC recommends routine use of RSV monoclonal antibody for infants Read More »
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial
Merck on July 27 announced positive Phase 3 results for a new pneumococcal conjugate vaccine, which targets several varieties of bacteria that cause pneumococcal pneumonia.
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial Read More »
NIH Innovation Zone: Phanes Biotech addresses neurodegenerative disease with a groundbreaking approach
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with